Elite Pharmaceuticals (ELTP) Short term Debt (2009 - 2026)
Elite Pharmaceuticals' Short term Debt came in at $240,170 for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 3.8% from $231,351 a year earlier and up 4.5% from the prior quarter.
Elite Pharmaceuticals (ELTP) Short term Debt (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Short term Debt was $228,596, down 7.3% from FY2025.
- Short term Debt has declined in each of the last six fiscal years, with a five-year compound annual growth rate of -11.1% (FY2021 to FY2026).
- Going back by fiscal year, Short term Debt was $246,566 in FY2025 (-16.8%), $296,221 in FY2024 (-4.7%), $310,854 in FY2023 (-12.1%) and $353,828 in FY2022 (-13.9%).
- The fiscal Q2 2027 figure represents the highest quarterly Short term Debt since fiscal Q4 2025.
- Year-over-year, Short term Debt increased in 1 of the last eight quarters, with an average decline of 16.4%.
- The fastest year-over-year change in Short term Debt over five years came in fiscal Q1 2024 (growth of 118.5%), and the weakest in fiscal Q1 2023 (a decline of 80.3%).
- Business Quant data shows ELTP's Short term Debt at $229,726 (Q1 2027), $228,596 (Q4 2026) and $227,502 (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,287.23 Bn | 1,260.84 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 685.24 Bn | 605.10 Bn | 17.30 Bn |
| 3 | AbbVie | 523.42 Bn | 491.43 Bn | 13.12 Bn |
| 4 | Merck | 361.12 Bn | 324.06 Bn | 13.19 Bn |
| 5 | Novartis Ag | 312.86 Bn | 286.10 Bn | - |
| 6 | Astrazeneca | 286.52 Bn | 260.04 Bn | 13.26 Bn |
| 7 | Amgen | 252.28 Bn | 203.93 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.33 Bn | 184.44 Bn | 6.73 Bn |
| 9 | Pfizer | 165.02 Bn | 112.37 Bn | 12.56 Bn |
| 10 | Elite Pharmaceuticals | 393.15 Mn | 266.57 Mn | 15.99 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 240,170.00 |
| Jun 30, 2026 | 229,726.00 |
| Mar 31, 2026 | 228,596.00 |
| Dec 31, 2025 | 227,502.00 |
| Sep 30, 2025 | 231,351.00 |
| Jun 30, 2025 | 230,621.00 |
| Mar 31, 2025 | 246,566.00 |
| Dec 31, 2024 | 289,999.00 |
| Sep 30, 2024 | 367,880.00 |
| Jun 30, 2024 | 429,608.00 |
| Mar 31, 2024 | 296,221.00 |
| Dec 31, 2023 | 306,429.00 |
| Sep 30, 2023 | 295,147.00 |
| Jun 30, 2023 | 251,276.00 |
| Mar 31, 2023 | 310,854.00 |
| Dec 31, 2022 | 471,438.00 |
| Sep 30, 2022 | 502,601.00 |
| Jun 30, 2022 | 115,000.00 |
| Mar 31, 2022 | 353,828.00 |
| Dec 31, 2021 | 400,423.00 |
Elite Pharmaceuticals Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();